Confirm that these devices are not imported: color Doppler ultrasound, DR, analyzer, ventilator...

Many medical device orders in Hunan Province clearly pointed out that it refused to import products

The bidding is clear: refusal to import

Recently, the public resource trading service platform of Hunan Province issued a bid-winning announcement.

The data shows that the color Doppler ultrasound bidding is divided into two packages, among which Lanyun Imaging and Mindray won the bid

The DR procurement was also divided into two packages.

The orders for the ambulances were obtained by Futian and Anwen, which were 70 and 60 units respectively, and the single unit prices were 178,000 yuan and 165,000 yuan respectively

The blood cell analyzer was awarded the bid by Mindray and Demai Biotech.

It is worth noting that it is clearly stated in the procurement requirements that the procurement refuses to import products

Coincidentally, the three medical equipment procurement announcements, including the "High-definition Medical Endoscope Camera System and Other Equipment Bidding Announcement" and "Multi-slice Spiral CT Procurement Project Public Bidding Announcement", were also issued today to reject imported products

It is also worth noting that the price of the winning equipment has decreased to varying degrees compared with the earlier purchase price

In other words, the localization of centralized procurement is not only beneficial to medical device manufacturers, but for medical institutions, the pressure on equipment procurement is also decreasing

Top-level design, frequent layout

In recent years, the country has been extremely frequent in the policy layout of promoting the localization of medical devices

As early as 2015, the "Made in China 2025" plan launched by the state clearly pointed out that in 2020, county-level hospitals will account for 50% of domestic high-end medical devices, and by 2025, they will account for 70%

In October of the following year, the state issued the "Health China 2030" Planning Outline, which pointed out that it should strengthen the construction of innovative capabilities such as high-end medical devices, accelerate the transformation and upgrading of medical devices, and improve the international competitiveness of medical diagnosis and treatment equipment and medical materials with independent intellectual property rights.

This year, the General Office of the State Council issued the "Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry", which pointed out that if domestic drugs and medical devices can meet the requirements, government procurement projects must in principle purchase domestic products, and gradually improve the level of domestic equipment allocation in public medical institutions

In June, the newly revised "Regulations on the Administration of Medical Devices" was formally implemented

According to the big data statistics of Zhongcheng Medical Devices, as of the end of June 2021, the number of domestic medical devices in the country reached 199469 pieces, an increase of 10.

On the other hand, as of the end of June, the number of registered medical device products with a localization rate of more than 50% in the secondary category was 1,523, a sharp increase from 518 in 2017
.

Some analysts pointed out that China has basically achieved domestic substitution in the fields of IVD biochemical diagnosis, monitors, coronary stents, and so on
.

Promote substitution, multi-provincial action

In recent years, the country has actively promoted the localization of medical equipment, and in addition to the country’s top-level design requirements, various localities have also actively explored and clearly restricted the import of medical equipment in order to promote the market share of domestic medical equipment
.

As the vanguard of medical reform, the Anhui Provincial Medical Insurance Bureau clearly pointed out in the consultation on the centralized procurement of large-scale Class B medical equipment in the province in December last year that the effect of scale should be exerted, the price of volume should be exchanged, and the purchase of domestic equipment should be encouraged.
Hospitals, the second and above large-scale medical equipment configuration, in principle, all choose domestically produced in actual implementation; public hospitals below the city and county level must choose domestically produced for the first configuration
.

In 2019, the Guangdong Provincial Health Commission issued the "Guangdong Province 2018-2020 Class B Large-scale Medical Equipment Configuration Planning and Technical Evaluation Standards (Trial) Notice".
The notice pointed out that public medical device users are encouraged to give priority to domestic self-owned brands of Class B Large-scale medical equipment, and gradually improve the level of domestic medical equipment configuration
.

Since 2021, Zhejiang Province, Guangdong Province, and Sichuan Province have all released the latest "Imported Medical Equipment Purchase List" to create favorable conditions for the promotion of domestically-made equipment
.

For example, in February of this year, the Zhejiang Provincial Department of Finance announced the "The Provincial Government Procurement of Imported Products (Medical Equipment) Uniform Demonstration List for 2021-2022".
There are 195 types of imported medical equipment that can be purchased in Zhejiang Province, compared with 215 in 2019.
20 species are reduced
.

The Guangdong side is even more aggressive.
The Guangdong Provincial Health Commission issued the "Announcement on the List of Imported Products of Provincial Health Institutions in 2021" in March.
The number of 205 species in the year decreased by 77.
56%
.

In April, the Sichuan Provincial Government Procurement Network published the "Provincial 2021-2022 Government Procurement Import Product List Demonstration Opinion Publicity (Medical and Sanitary Equipment)", showing that only 59 types of medical equipment can be imported
.

With the combination of favorable policies and the gradual increase in innovation by enterprises, the day when more domestic substitutions appear in the medical industry should not be far away
.